Skip to main content
Smart Investors Daily
SX

NASDAQ · SXTC

China SXT Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$2.65

Up+$0.06 (+2.12%)

Updated Nov 21, 2026, 4:54 AM

SID Score

3.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
157.8M
P/E ratio
-1.01
Dividend yield
0.00%
52-week range
$0.05 – $1,046.99
Volume
25.33K
Avg. volume
136.47K

Price performance · SXTC

SXTC price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 20, 2026

SXTC closed at $2.65 after 21 trading sessions, down 35.49% for the selected period.

Last close
$2.65
Period change
-35.49%
Period low
$2.59
Period high
$4.10
Daily close
View OHLC price history
SXTC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 20, 2026$2.75$2.76$2.60$2.64525.33K
Nov 19, 2026$2.85$2.91$2.521$2.5955.5K
Nov 18, 2026$2.89$2.91$2.83$2.8333.07K
Nov 17, 2026$2.84$2.90$2.80$2.8638.01K
Nov 16, 2026$2.96$3.01$2.87$2.9963.99K
Nov 13, 2026$2.90$3.44$2.81$3.00228.1K
Nov 12, 2026$2.88$2.94$2.73$2.7351.48K
Nov 11, 2026$2.81$3.01$2.80$2.8351.46K
Nov 10, 2026$2.94$3.019$2.80$2.8893.73K
Nov 9, 2026$2.99$3.15$2.89$3.10113.59K
Nov 6, 2026$2.92$3.07$2.8106$2.8339.02K
Nov 5, 2026$3.05$3.05$2.76$2.9353.52K
Nov 4, 2026$2.85$3.40$2.84$2.98127.27K
Nov 3, 2026$2.80$3.07$2.71$2.8871K
Nov 2, 2026$3.12$3.12$2.71$2.7874.27K
Oct 30, 2026$3.35$3.5379$3.07$3.25108.67K
Oct 29, 2026$3.59$3.70$3.51$3.5576.55K
Oct 28, 2026$3.81$3.8297$3.4601$3.68172.47K
Oct 27, 2026$3.47$4.07$3.28$3.55237.05K
Oct 26, 2026$4.15$4.2307$3.37$3.54204.98K
Oct 23, 2026$4.21$4.55$3.81$4.10227.41K

Latest SXTC news

The latest Smart Investors Daily articles mentioning SXTC.

SXTC research

Overview

Company profile and research snapshot.

Company profile

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 15, 2026

CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN

TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced as part of its Artificial Intelligence (AI) Insight

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.